Numeco, an affiliate of Medytox, said on the 10th that it held a kickoff meeting to achieve its business goals. Numeco distributes Medytox's Botox (botulinum toxin product) and fillers.
Lee Sang-yoon, head of Numeco, explained this year's business plans and strategies at the meeting. Numeco plans to increase the market share of NEWLUX Botox, launched in 2023, and speed up its overseas expansion. NEWLUX is expanding its presence in Korea, Europe, Latin America, and Asia.
The company plans to raise awareness of Neuramis Heart and Neuramis Skin Enhancer, new hyaluronic acid filler products launched last year. To that end, it will run online ads linked with major hospitals' social media (SNS). It will also expand region-specific customized training and seminars, academic events, and invited lectures.
Lee said, "We exceeded our sales target with aggressive marketing last year," adding, "We will leverage our sales power to defend the No. 1 market share in the domestic toxin and filler markets and focus on overseas exports."